



















Exploration of genomic signals controlling energy metabolism and its application
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研究成果の概要（英文）：Energy metabolic control of an individual is performed with high accuracy 
referring to the nucleotide sequence of the genome. How do we respond to fasting and feeding? From 
this point of view, we have tried to comprehensively understand glucose and lipid metabolism. In 
this study, the in vivo Ad-luc analytical method and the TFEL scan method, which we have 
independently developed over the past few years, temporally and spatially resolve various signals 
controlling energy metabolism. As a result of searching for an unknown nuclear information 
processing mechanism responsible for energy metabolism, a part of the processing mechanism became 
clear, which can lead to the development of therapeutic strategies for lifestyle / obesity-related 














に作用すること(Ide, Shimano, Yahagi, et al. 


















































 in vivo Ad-luc解析法により、SREBP-1 の
上流の制御因子として我々が最近同定した、
糖代謝と脂質代謝を繋ぐ重要な転写因子




 また、これらの機能性 cis-element に作用
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仁：脂肪組織における in vivo Ad-luc 法に
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